Mail

UK markets closed

FTSE 100
8,144.77
+65.91(+0.82%)
FTSE 250
19,818.20
+216.22(+1.10%)
AIM
755.38
+2.26(+0.30%)
GBP/EUR
1.1661
+0.0005(+0.04%)
GBP/USD
1.2469
-0.0042(-0.34%)
Bitcoin GBP
50,936.89
-298.97(-0.58%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Bioceres Crop Solutions Corp. (BIOX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

12.11

+0.03

(+0.25%)

As of 11:31AM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	731.69M
Enterprise value	926.88M
Trailing P/E	34.50
Forward P/E	9.75
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	1.69
Price/book (mrq)	2.43
Enterprise value/revenue	2.04
Enterprise value/EBITDA	14.31

Trading information

Stock price history

Beta (5Y monthly)	0.58
52-week change ³	7.76%
S&P500 52-week change ³	21.08%
52-week high ³	14.20
52-week low ³	9.76
50-day moving average ³	12.76
200-day moving average ³	12.26

Share statistics

Avg vol (3-month) ³	64.36k
Avg vol (10-day) ³	35.75k
Shares outstanding ⁵	60.57M
Implied shares outstanding ⁶	62.85M
Float ⁸	19.91M
% held by insiders ¹	51.09%
% held by institutions ¹	31.28%
Shares short (15 Apr 2024) ⁴	280.45k
Short ratio (15 Apr 2024) ⁴	8.42
Short % of float (15 Apr 2024) ⁴	1.00%
Short % of shares outstanding (15 Apr 2024) ⁴	0.46%
Shares short (prior month 15 Mar 2024) ⁴	291.18k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Jun 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	4.83%
Operating margin (ttm)	10.54%

Management effectiveness

Return on assets (ttm)	3.93%
Return on equity (ttm)	7.24%

Income statement

Revenue (ttm)	454.53M
Revenue per share (ttm)	7.24
Quarterly revenue growth (yoy)	48.40%
Gross profit (ttm)	N/A
EBITDA	68.36M
Net income avi to common (ttm)	21.96M
Diluted EPS (ttm)	0.35
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	41.44M
Total cash per share (mrq)	0.66
Total debt (mrq)	236.64M
Total debt/equity (mrq)	70.58%
Current ratio (mrq)	1.24
Book value per share (mrq)	4.78

Cash flow statement

Operating cash flow (ttm)	29.55M
Levered free cash flow (ttm)	16.7M